Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ie-Ming Shih

Showing results (141-150 of 364) with videos related to

Pageof 37
Sort By:
Cancer Research|August 9, 2024
Dual Inhibition of SYK and EGFR Overcomes Chemoresistance by Inhibiting CDC6 and Blocking DNA ReplicationJayaprakash Mandal, Tiffany Nicole Jones, Juliane Marie Liberto, et al.
The American Journal of Surgical Pathology|May 23, 2009
Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysisAyse Ayhan, Robert J Kurman, Anna Yemelyanova, et al.
International Journal of Cancer|March 14, 2007
Amplicon profiles in ovarian serous carcinomasKentaro Nakayama, Naomi Nakayama, Natini Jinawath, et al.
BMC Bioinformatics|October 8, 2008
Knowledge-guided multi-scale independent component analysis for biomarker identificationLi Chen, Jianhua Xuan, Chen Wang, et al.
Journal of Cellular and Molecular Medicine|February 6, 2010
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusionsBen Davidson, Helene Tuft Stavnes, Arild Holth, et al.
Cancer Research|July 18, 2008
Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesionJung-Hye Choi, Joon T Park, Ben Davidson, et al.
Journal of the National Cancer Institute|March 20, 2003
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinomaGad Singer, Robert Oldt, Yoram Cohen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 10, 2011
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysisAnna Yemelyanova, Russell Vang, Malti Kshirsagar, et al.
The American Journal of Surgical Pathology|July 23, 2009
Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 casesAnna Yemelyanova, Hongxiu Ji, Ie-Ming Shih, et al.
Placenta|October 26, 2002
The Role of E-cadherin in the Motility and Invasion of Implantation Site Intermediate TrophoblastIe-Ming Shih, Mei-Yu Hsu, Robert J Oldt, et al.
Pageof 37

Showing results (141-150 of 364) with videos related to

Sort By:
Pageof 37
Cancer Research|August 9, 2024
Dual Inhibition of SYK and EGFR Overcomes Chemoresistance by Inhibiting CDC6 and Blocking DNA ReplicationJayaprakash Mandal, Tiffany Nicole Jones, Juliane Marie Liberto, et al.
The American Journal of Surgical Pathology|May 23, 2009
Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysisAyse Ayhan, Robert J Kurman, Anna Yemelyanova, et al.
International Journal of Cancer|March 14, 2007
Amplicon profiles in ovarian serous carcinomasKentaro Nakayama, Naomi Nakayama, Natini Jinawath, et al.
BMC Bioinformatics|October 8, 2008
Knowledge-guided multi-scale independent component analysis for biomarker identificationLi Chen, Jianhua Xuan, Chen Wang, et al.
Journal of Cellular and Molecular Medicine|February 6, 2010
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusionsBen Davidson, Helene Tuft Stavnes, Arild Holth, et al.
Cancer Research|July 18, 2008
Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesionJung-Hye Choi, Joon T Park, Ben Davidson, et al.
Journal of the National Cancer Institute|March 20, 2003
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinomaGad Singer, Robert Oldt, Yoram Cohen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 10, 2011
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysisAnna Yemelyanova, Russell Vang, Malti Kshirsagar, et al.
The American Journal of Surgical Pathology|July 23, 2009
Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 casesAnna Yemelyanova, Hongxiu Ji, Ie-Ming Shih, et al.
Placenta|October 26, 2002
The Role of E-cadherin in the Motility and Invasion of Implantation Site Intermediate TrophoblastIe-Ming Shih, Mei-Yu Hsu, Robert J Oldt, et al.
Pageof 37